Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2026-01-05 @ 11:26 PM
Study NCT ID:
NCT00333294
Status:
COMPLETED
Last Update Posted:
2007-12-19
First Post:
2006-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Iressa + Irradiation Followed by Chemo in NSCLC
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1839IL/0530
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None